普米克气雾剂

目的观察普米克气雾剂治疗儿童哮喘前后的最高呼气峰流速值（PEF）及血清嗜酸细胞阳离子蛋白（ECP）的变化。

Objective To observe the differences of peak expiratory flow ( PEF ), and serum eosinophil cationic protein ( ECP ) before and after Pulmicort aerosol inhalation for childhood asthma .

方法对113例儿童哮喘病人，使用普米克气雾剂[（200～800）μg/d]，3月～1年。

Methods 113 asthmatic children treated with Pulmicort aerosol [ ( 200 ~ 800 ) μ g / d ] for ( 3 ~ 12 ) months were studied .

研究表明，长期吸入普米克气雾剂400～1000μg／日对肾上腺皮质功能、血细胞无明显影响，为一安全剂量。

It indicate that there is no obvious influence for patients to inhale pulmicort 400 ~ 1 000 μ g each day over a long period of time and the amount of pulmicort is proved to be a safe dose for patients .

全部病人出院后均采用普米克气雾剂200ug～400ug/d雾化吸入，持续3个月。

After leaving the hospital , all the cases were given a dose of 200 μ g ~ 400 μ g / d pulmicort Respules by breathed in and it was continued for 3 months .

普米克气雾剂对肾上腺皮质功能、血免疫球蛋白及血细胞的影响

Influence of pulmicort on blood cells , immune serum globulin and adrenocortical function

普米克气雾剂平喘疗效的临床研究

Clinical study on antiasthmatic effects of Pulmicort inhalation

每天1次吸入普米克气雾剂治疗儿童轻度持续哮喘疗效评价

The effectiveness of once-daily vs twice-daily dosing of inhaled budesonide in mild persistent asthma in children

目的评价每天吸入1次普米克气雾剂（200μg/d）治疗儿童轻度持续哮喘的疗效。

Objective To evaluate the effects of one-daily inhaled budesonide ( BUD ) on mild persistent asthma in children .